Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Long-Term Deferred Tax (2016 - 2022)

Orthofix Medical (OFIX) has disclosed Long-Term Deferred Tax for 13 consecutive years, with $1.5 million as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Long-Term Deferred Tax fell 93.21% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2022, down 93.21%, and an annual FY2021 reading of $1.8 million, down 92.93% over the prior year.
  • Long-Term Deferred Tax was $1.5 million for Q3 2022 at Orthofix Medical, up from $1.5 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $36.6 million in Q1 2019 and bottomed at $1.5 million in Q2 2022.
  • Average Long-Term Deferred Tax over 5 years is $22.5 million, with a median of $26.1 million recorded in 2021.
  • The sharpest move saw Long-Term Deferred Tax skyrocketed 42.52% in 2018, then plummeted 93.21% in 2022.
  • Year by year, Long-Term Deferred Tax stood at $33.2 million in 2018, then increased by 5.68% to $35.1 million in 2019, then dropped by 28.69% to $25.0 million in 2020, then tumbled by 92.93% to $1.8 million in 2021, then decreased by 12.82% to $1.5 million in 2022.
  • Business Quant data shows Long-Term Deferred Tax for OFIX at $1.5 million in Q3 2022, $1.5 million in Q2 2022, and $1.9 million in Q1 2022.